✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
Hong Kong Exchanges and Clearing Limited
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's Waste Data Preview

In 2025, Innovent Biologics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2025
Total Waste Generated
1,074.29a
Total Waste Recovered
N/A
Total Hazardous Waste Generated
545.29a
Non-Hazardous Waste Disposed
N/A
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Innovent Biologics’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Innovent Biologics's ESG Report 2025

Insights into Innovent Biologics’s Generation of Hazardous and Non-Hazardous Waste

In 2025, Innovent Biologics generated a total of 1,074 metric tonnes of waste.a

Of this amount, 50.76% of Innovent Biologics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.49.24% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

Want Full Access to Innovent Biologics's Waste Management Dataset?
Start 30-Day Free Trial